Targeting tumor necrosis factor α in psoriasis and psoriatic arthritis

Author： Fantuzzi Francesca Del Giglio Micol Gisondi Paolo Girolomoni Giampiero

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.12, Iss.9, 2008-09, pp. : 1085-1096

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting Tumor Necrosis Factor- in the Therapy of Psoriasis

Current Drug Targets. Inflammation & Allergy, Vol. 3, Iss. 2, 2004-06 ,pp. : 175-183

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical images: Multi‐modality imaging monitoring of anti–tumor necrosis factor α treatment at the joint and skin level in psoriatic arthritis

Arthritis & Rheumatism, Vol. 62, Iss. 12, 2010-12 ,pp. : 3829-3829

John Wiley & Sons Inc

Access to resources Recommend Favorite

Biologic Therapy in Psoriasis (Part I): Efficacy and Safety of Tumor Necrosis Factor- α Inhibitors

Current Pharmaceutical Biotechnology, Vol. 18, Iss. 12, 2018-03 ,pp. : 945-963

Bentham Science Publishers

Access to resources Recommend Favorite

Tumor Necrosis Factor Inhibitors as Therapeutic Choice in Psoriasis

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 8, Iss. 1, 2009-03 ,pp. : 47-50

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenomics of tumor necrosis factor antagonists in rheumatoid arthritis

By Ranganathan Prabha

Pharmacogenomics, Vol. 6, Iss. 5, 2005-07 ,pp. : 481-490

Future Medicine

Access to resources Recommend Favorite